Livongo Health (NASDAQ:LVGO) Shares Gap Up After Analyst Upgrade

Livongo Health (NASDAQ:LVGO) gapped up before the market opened on Friday after Piper Jaffray Companies raised their price target on the stock from $40.00 to $41.00. The stock had previously closed at $23.05, but opened at $24.43. Piper Jaffray Companies currently has an overweight rating on the stock. Livongo Health shares last traded at $24.87, with a volume of 17,016 shares traded.

A number of other analysts have also issued reports on LVGO. Goldman Sachs Group started coverage on shares of Livongo Health in a research report on Monday, August 19th. They set a “buy” rating and a $43.00 target price on the stock. Morgan Stanley upgraded shares of Livongo Health from an “equal weight” rating to an “overweight” rating and set a $42.00 target price on the stock in a research report on Wednesday, August 28th. JPMorgan Chase & Co. started coverage on shares of Livongo Health in a research report on Monday, August 19th. They set an “overweight” rating and a $43.00 target price on the stock. Leerink Swann started coverage on shares of Livongo Health in a research report on Monday, August 19th. They set an “outperform” rating and a $50.00 target price on the stock. Finally, Chardan Capital started coverage on shares of Livongo Health in a research report on Friday, August 16th. They set a “neutral” rating and a $40.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Livongo Health has a consensus rating of “Buy” and a consensus target price of $44.30.

Several institutional investors and hedge funds have recently made changes to their positions in LVGO. Emerald Advisers LLC acquired a new position in shares of Livongo Health in the 3rd quarter valued at $1,342,000. Emerald Mutual Fund Advisers Trust acquired a new position in shares of Livongo Health in the 3rd quarter valued at $1,292,000. Pembroke Management LTD acquired a new position in shares of Livongo Health in the 3rd quarter valued at $1,128,000. Dean Capital Investments Management LLC acquired a new position in shares of Livongo Health in the 3rd quarter valued at $275,000. Finally, Rhumbline Advisers acquired a new position in shares of Livongo Health in the 3rd quarter valued at $238,000. Institutional investors own 0.10% of the company’s stock.

The company’s fifty day simple moving average is $20.18.

Livongo Health (NASDAQ:LVGO) last announced its quarterly earnings results on Wednesday, November 6th. The company reported ($0.05) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.28) by $0.23. The company had revenue of $46.70 million during the quarter, compared to analyst estimates of $42.77 million. The firm’s revenue for the quarter was up 148.7% compared to the same quarter last year. During the same quarter last year, the business earned ($0.55) EPS. On average, research analysts expect that Livongo Health will post -1.29 earnings per share for the current year.

About Livongo Health (NASDAQ:LVGO)

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Featured Story: The Discount Rate – What You Need to Know

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.